Brain Cancer

Metastatic Breast Cancer

Breast Cancer

Colorectal Cancer

Gastric Cancers

Liver Cancer

Gastrointestinal Cancer

Bladder Cancer

Kidney Cancer

Prostate Cancer

Genitourinary Cancer

Cervical Cancer

Endometrial Cancer

Ovarian Cancer

Gynecologic Cancers

Head and Neck Cancers

Graft-Vs-Host Disease

Leukemia

Lymphoma

Multiple Myeloma

Myeloproliferative Neoplasms

Hematology

Lung Cancer

Pediatric Cancer

Sarcomas

Melanoma

Skin Cancer

Data from a research database link ctDNA positivity in early breast cancer with poorer survival and higher recurrence risk.

Real-World Data Tie Early Breast Cancer ctDNA to Recurrence, Lower OS

ALLO-316 showed significant activity and safety in patients with metastatic CD70-positive clear cell renal cell carcinoma.

Allogenic CAR T-Cell Agent Safe, Active in Heavily Pretreated RCC

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at the 2025 ASCO Meeting.

No Survival, Recurrence Benefit With Aspirin in CRC Liver Metastases

The combination of relacorilant and nab-paclitaxel improved survival in platinum-resistant ovarian cancer following a break from platinum-based chemo.

Relacorilant Combo Sustains Ovarian Cancer Benefit Post Platinum Break

News

Latest News

FDA News

Adverse Event Management

Supportive Care

Disparities in Cancer Care

Drug Safety

Radiation Oncology

Survivorship 

Practice Management

Prevention

Contributors

Media

Expert Connections

Morning Rounds

The Vitals

Podcasts

Videos

Between the Lines

From All Angles

Meeting of the Minds

Training Academy

Conferences

Conference Coverage

Conference Listing

Publications

CME/CE

Continuing Education

Resources

Case-Based Digest 

Rx Road Map

Webinars

Cancer Summary Slides

MPN Symptom Management

Events

Subscribe

Partners

Hope Rugo is a leading medical oncologist in the breast cancer space whose work in clinical trials has led to approvals of antibody-drug conjugates, CDK4/6 inhibitors, PI3k inhibitors, PARP inhibitors, and checkpoint inhibitors, among others. Her work has also resulted in approvals of a scalp cooling cap preventative of chemotherapy-related hair loss along with a steroid mouthwash for the management of stomatitis.

Bridget Hoyt is the assistant editor for Oncology Nursing News. She earned her BA in communication studies at Rider University with a minor in public relations. She can be reached at 

If patients with breast cancer hyperglycemia or symptoms of it at home, a short break from capivasertib may be required, according to Hope Rugo, MD.

Capivasertib Break May Be Needed in Patients With Breast Cancer Experiencing Hyperglycemia

Russ Conroy is an Assistant Editor for CancerNetwork. He grew up in Hillsborough, New Jersey, and graduated from Rutgers University-New Brunswick in 2022.

On the weekends, he likes to unwind by playing video games with friends, tailgating at Rutgers football games with his family, or building his music collection with a visit to Princeton Record Exchange.

Articles

Most patients demonstrated at least partial response to tarlatamab in a real-world population with extensive-stage small cell lung cancer.

Tarlatamab Yields Response in Real-World ES-SCLC Population

Erika Hamilton is the director of breast and gynecologic cancer research at Sarah Cannon Research Institute in Nashville, Tennessee.

New therapies in breast cancer, particularly ADCs, present unique safety profiles for nurses to be aware of, according to Erika Hamilton, MD.

Safety Profiles to Look Out For in New Breast Cancer Treatments

Jax DiEugenio joined MJH Life Sciences in 2024, first as an editorial intern before transitioning into a full-time assistant editor for 

. A recent College of New Jersey graduate, Jax majored in Journalism/ Professional Writing with minors in Public Health and Anthropology. He is also pursuing a Master's Degree in Public Health, concentrating on health communications.

 in November 2021 as a senior editor and became the website's managing editor in October 2023. Before arriving at MJH Life Sciences, he spent nearly a decade covering professional and high school sports—including the New Jersey Devils and the NHL from 2016 to 2021—for The Star-Ledger and NJ.com. Email: chryan@onclive.com

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.

About Us

Editorial Board

Contact Us

CancerNetwork.com

CureToday.com

OncLive.com

TargetedOnc.com

Advertise

Privacy

Terms & Conditions

Do Not Sell My Information

Oncology Nursing News – Clinical Insights for Cancer Care Nurses

Facebook

LinkedIn

Specialty

Advanced Practice Providers

Clinical

Gynecologic Cancer

Immunotherapy

Nurse Navigation

Quality Improvement

1rem

Does selenium prevent the development of cancer? Recent Cochrane meta-analysis says no.

Study Claims Selenium Does Not Prevent the Development of Cancer

New research supports the use of exemestane

Reducing the Risk of Invasive Breast Cancer

'Over-warning' or necessary adverse drug event information?

Drug Label Overload

Weekend hospital admissions linked to higher patient mortality.

Watch Out for the Weekend

Higher levels of norepinephrine are found in women with persistent fatigue.

New Information about Fatigue Experienced by Breast Cancer Survivors

Singer and songwriter Charlie Lustman has become an inspirational voice for the over 12 million cancer survivors living in the United States

Osteosarcoma Survivor Sings Message of Hope

Half of US states currently have anti-smoking laws; the goal is 100%

Smoking Bans

The release of the data was a requirement of the national health care reform act.

Medicare Data on Healthcare Errors Released

Help kidney cancer patients by being aware of available resources and support services

Resources for People Living with Kidney Cancer

News

Latest Conference Coverage